BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 1999
View Archived Issues
COX-2 inhibitors can potentially be used safely in patients with decompensated cirrhosis
Read More
PEG-conjugated prodrugs of anticancer compounds in development at Enzon
Read More
Schwarz acquires Spanish firm
Read More
Wide series of cytokine production inhibitors reported by JT
Read More
Phenoxypyridine inhibitors of Na+/Ca2+ exchange from Taisho
Read More
HPV-33 DNA fragments useful in diagnosis of HPV and cervical carcinoma
Read More
Hericenal C: new enzyme inhibitor for diabetes mellitus
Read More
FDA approves amprenavir, first new protease inhibitor in more than two years
Read More
SBIR grant to CoCensys for analgesic discovery
Read More
Potent, orally bioavailable NK3 antagonist under study at Warner-Lambert
Read More
T-2585.HCl: a novel, potent and selective PDE4 inhibitor with potential as asthma Rx
Read More
Furosemide prevents sound-induced seizures in rat model
Read More
Immune Response describes herpes vaccine research at FASEB 99
Read More
CGP-57148B useful for overcoming resistance to etoposide- and daunorubicin-induced apoptosis
Read More
Phosphodiesterase inhibition contributes to the antiinflammatory activity of darbufelone
Read More
SciClone and Sigma-Tau sign Zadaxin partnership
Read More
News from FASEB: serine protease inhibitor prevents reperfusion injury in preclinical model
Read More
Resistance profile of novel apoptosis inducer characterized in preliminary studies
Read More
CD-437: new apoptogenic retinoid examined for resistance using leukemia cells
Read More
Preclinical and early clinical data reported for DX-8951f at AACR meeting
Read More
CardioRex versus probucol in atherosclerosis model
Read More
Bay-y-5959 is not associated with proarrhythmic activity in dogs with CHF
Read More
NX-211 compared to free lurtotecan regarding pharmacokinetics, toxicity and efficacy
Read More
News from FASEB: ETA antagonist with potential in the treatment of pulmonary hypertension
Read More
European Commission approves novel albumin-free treatment for hemophilia A
Read More
News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity
Read More
News from FASEB: dermal pharmacology of Dekk-Tec's A-007
Read More
Immunological response to GMK melanoma vaccine examined as part of phase III trial
Read More